BACKGROUND: We compared values of baseline serum cystatin C (SCysC), serum creatinine (SCr), and measured glomerular filtration rate (mGFR) for predicting end-stage renal disease (ESRD) in patients with type 2 diabetes and elevated albuminuria. STUDY DESIGN: Observational longitudinal study. SETTING & PARTICIPANTS: Pima Indians with type 2 diabetes and elevated albumin-creatinine ratio (ACR ≥30 mg/g). PREDICTORS: Baseline SCysC, SCr, and mGFR. OUTCOMES & MEASUREMENTS: Individuals were followed up from their first examination with diabetes and ACR ≥30 mg/g until December 2010, onset of ESRD, or death, whichever came first. Incidence rates adjusted for age and sex were computed by Mantel-Haenszel stratification. The abilities of SCysC, SCr, and mGFR values to predict ESRD were compared with receiver operating characteristic curves. RESULTS: Of 234 Pima Indians with a mean age of 42.8 years who were followed up for a median of 10.7 (range, 0.6-21.3) years, 68 (29%) developed ESRD. The incidence of ESRD was significantly higher in patients in the lowest versus highest tertile of 1/SCysC (incidence rate ratio, 2.43; 95% CI, 1.31-4.50). By contrast, mGFR and 1/SCr had J-shaped associations with ESRD. In unadjusted analyses, 1/SCysC had the highest area under the receiver operating characteristic curve (AUROC; 0.719 ± 0.035) and mGFR had the lowest (0.585 ± 0.042; P < 0.001); the AUROC for 1/SCr was intermediate (0.672 ± 0.040; P = 0.1 and P = 0.03 vs 1/SCysC and mGFR, respectively). In analyses adjusted for age, sex, diabetes duration, height, weight, hemoglobin A1c level, and ACR, 1/SCysC had the highest AUROC (0.845 ± 0.026). Models with mGFR or 1/SCr alone had similar AUROCs (P = 0.9) and both were lower than the model with 1/SCysC alone (P = 0.02 and P = 0.03, respectively). LIMITATIONS: The predictive values of the filtration markers are limited to the extent that their precision is based on a single measurement. CONCLUSIONS: SCysC level was a better predictor of ESRD than mGFR or SCr level in Pima Indians with type 2 diabetes and elevated albuminuria. Published by Elsevier Inc.
BACKGROUND: We compared values of baseline serum cystatin C (SCysC), serum creatinine (SCr), and measured glomerular filtration rate (mGFR) for predicting end-stage renal disease (ESRD) in patients with type 2 diabetes and elevated albuminuria. STUDY DESIGN: Observational longitudinal study. SETTING & PARTICIPANTS: Pima Indians with type 2 diabetes and elevated albumin-creatinine ratio (ACR ≥30 mg/g). PREDICTORS: Baseline SCysC, SCr, and mGFR. OUTCOMES & MEASUREMENTS: Individuals were followed up from their first examination with diabetes and ACR ≥30 mg/g until December 2010, onset of ESRD, or death, whichever came first. Incidence rates adjusted for age and sex were computed by Mantel-Haenszel stratification. The abilities of SCysC, SCr, and mGFR values to predict ESRD were compared with receiver operating characteristic curves. RESULTS: Of 234 Pima Indians with a mean age of 42.8 years who were followed up for a median of 10.7 (range, 0.6-21.3) years, 68 (29%) developed ESRD. The incidence of ESRD was significantly higher in patients in the lowest versus highest tertile of 1/SCysC (incidence rate ratio, 2.43; 95% CI, 1.31-4.50). By contrast, mGFR and 1/SCr had J-shaped associations with ESRD. In unadjusted analyses, 1/SCysC had the highest area under the receiver operating characteristic curve (AUROC; 0.719 ± 0.035) and mGFR had the lowest (0.585 ± 0.042; P < 0.001); the AUROC for 1/SCr was intermediate (0.672 ± 0.040; P = 0.1 and P = 0.03 vs 1/SCysC and mGFR, respectively). In analyses adjusted for age, sex, diabetes duration, height, weight, hemoglobin A1c level, and ACR, 1/SCysC had the highest AUROC (0.845 ± 0.026). Models with mGFR or 1/SCr alone had similar AUROCs (P = 0.9) and both were lower than the model with 1/SCysC alone (P = 0.02 and P = 0.03, respectively). LIMITATIONS: The predictive values of the filtration markers are limited to the extent that their precision is based on a single measurement. CONCLUSIONS: SCysC level was a better predictor of ESRD than mGFR or SCr level in Pima Indians with type 2 diabetes and elevated albuminuria. Published by Elsevier Inc.
Authors: Nrupen A Bhavsar; Lawrence J Appel; John W Kusek; Gabriel Contreras; George Bakris; Josef Coresh; Brad C Astor Journal: Am J Kidney Dis Date: 2011-09-22 Impact factor: 8.860
Authors: Anoop Shankar; Liping Sun; Barbara E K Klein; Kristine E Lee; Paul Muntner; F Javier Nieto; Michael Y Tsai; Karen J Cruickshanks; Carla R Schubert; Peter C Brazy; Josef Coresh; Ronald Klein Journal: Kidney Int Date: 2011-08-24 Impact factor: 10.612
Authors: Michael G Shlipak; Mark J Sarnak; Ronit Katz; Linda F Fried; Stephen L Seliger; Anne B Newman; David S Siscovick; Catherine Stehman-Breen Journal: N Engl J Med Date: 2005-05-19 Impact factor: 91.245
Authors: J P E Lassus; V-P Harjola; K Peuhkurinen; R Sund; A Mebazaa; K Siirilä-Waris; K Miettinen; K R Punnonen; J Melin; K Pulkki; M S Nieminen Journal: Biomarkers Date: 2011-03-21 Impact factor: 2.658
Authors: Meredith C Foster; Lesley A Inker; Chi-Yuan Hsu; John H Eckfeldt; Andrew S Levey; Meda E Pavkov; Bryan D Myers; Peter H Bennett; Paul L Kimmel; Ramachandran S Vasan; Josef Coresh; Robert G Nelson Journal: Am J Kidney Dis Date: 2015-03-12 Impact factor: 8.860
Authors: Elaine Ku; Dawei Xie; Michael Shlipak; Amanda Hyre Anderson; Jing Chen; Alan S Go; Jiang He; Edward J Horwitz; Mahboob Rahman; Ana C Ricardo; James H Sondheimer; Raymond R Townsend; Chi-Yuan Hsu Journal: J Am Soc Nephrol Date: 2015-11-24 Impact factor: 10.121
Authors: Sudha K Iyengar; John R Sedor; Barry I Freedman; W H Linda Kao; Matthias Kretzler; Benjamin J Keller; Hanna E Abboud; Sharon G Adler; Lyle G Best; Donald W Bowden; Allison Burlock; Yii-Der Ida Chen; Shelley A Cole; Mary E Comeau; Jeffrey M Curtis; Jasmin Divers; Christiane Drechsler; Ravi Duggirala; Robert C Elston; Xiuqing Guo; Huateng Huang; Michael Marcus Hoffmann; Barbara V Howard; Eli Ipp; Paul L Kimmel; Michael J Klag; William C Knowler; Orly F Kohn; Tennille S Leak; David J Leehey; Man Li; Alka Malhotra; Winfried März; Viji Nair; Robert G Nelson; Susanne B Nicholas; Stephen J O'Brien; Madeleine V Pahl; Rulan S Parekh; Marcus G Pezzolesi; Rebekah S Rasooly; Charles N Rotimi; Jerome I Rotter; Jeffrey R Schelling; Michael F Seldin; Vallabh O Shah; Adam M Smiles; Michael W Smith; Kent D Taylor; Farook Thameem; Denyse P Thornley-Brown; Barbara J Truitt; Christoph Wanner; E Jennifer Weil; Cheryl A Winkler; Philip G Zager; Robert P Igo; Robert L Hanson; Carl D Langefeld Journal: PLoS Genet Date: 2015-08-25 Impact factor: 5.917